Gladstone in the News
October 18, 2020
San Francisco Chronicle—Some of the treatments the president received for COVID-19 were developed using cells derived from human embryonic tissue. In addition, many of the COVID-19 vaccine candidates were developed using fetal cell lines. Gladstone Senior Investigator Warner Greene explains how valuable fetal tissue research has been to research on cancer, HIV, spinal cord injuries, and many other diseases. He also describes how the president’s 2019 decision to cut federal funding for fetal cell research has damaged that progress.
Gladstone Experts
COVID-19
Virology
Greene Lab
Gladstone in the News
October 18, 2020
abc News—In 2019, the Trump administration suspended federal funding for research involving fetal tissue. Gladstone President Deepak Srivastava explains that if the funding ban had been in place over the last few decades, many important drugs—including treatments for COVID-19—would not have been developed.
Gladstone Experts
COVID-19
Roddenberry Stem Cell Center
Srivastava Lab
Stem Cells/iPSCs
Gladstone in the News
October 17, 2020
Science is Fun!—Director of the Gladstone Institute of Virology Melanie Ott describes her latest work developing a CRISPR-based test for COVID-19, and the prospect for broadly acting antiviral therapeutics.
Gladstone Experts
COVID-19
Virology
Ott Lab
Gladstone in the News
October 14, 2020
abc News—Gladstone President Deepak Srivastava, MD, comments on the fact that the experimental treatments President Trump received for COVID-19 were tested on cells that were derived from fetal tissue decades ago, and expresses concern that the Trump administration's current ban on the use of fetal tissue for research could slow efforts to curb the pandemic.
Gladstone Experts
COVID-19
Cardiovascular Disease
Srivastava Lab
Gladstone in the News
October 12, 2020
POZ—Finding a cure to HIV will require a full understanding of the latent reservoir, the population of cells in which the virus hides, evading antiretroviral therapy. Gladstone scientist Nadia Roan describes her recent work mapping an atlas of the reservoir, and how it provides hope that new therapies could be developed to target and eliminate reservoir cells.
Gladstone Experts
HIV/AIDS
Virology
Roan Lab
Gladstone in the News
October 8, 2020
The New York Times—The experimental drugs used to treat President Trump for COVID-19 were developed with the help of a human cell line derived from a fetus aborted decades ago. Gladstone President Deepak Srivastava, MD, and Senior Investigator Warner Greene, MD, PhD, comment on the ethics of accepting this treatment while also banning research using newly derived fetal cells, in the process thwarting the development of life-saving treatments for other conditions.
Gladstone Experts
COVID-19
Cardiovascular Disease
Center for HIV Cure Research
Greene Lab
Srivastava Lab
Gladstone in the News
October 5, 2020
San Francisco Chronicle—After the president was diagnosed with COVID-19, he received aggressive medical treatment. Gladstone Senior Investigator Warner Greene noted that the combination of drugs the president received has not been tested or proven effective, and that the dexamethasone he was given is a sign his illness might be more severe than it appears.
Gladstone Experts
COVID-19
Virology
Greene Lab
Gladstone in the News
October 2, 2020
Clinical Omics—Alex Marson, MD, PhD, director of the Gladstone-UCSF Institute of Genomic Immunology, explains his lab's recent discovery of the the gene networks that distinguish regulatory T cells from other types of T cells, and the implication for therapies against cancer and autoimmune diseases.
Gladstone Experts
Autoimmune Diseases
Marson Lab
Gladstone in the News
October 1, 2020
Technology Network—Senior Investigator Bruce Conklin, MD, explains how SARS-CoV-2 damages heart cells and how heart cells grown in the lab could be used to screen for drugs against infection by the novel coronavirus.
Gladstone Experts
COVID-19
Cardiovascular Disease
Conklin Lab
Gladstone in the News
October 1, 2020
Genetic Engineering and Biotechnology News—Alex Marson, MD, PhD, director of the Gladstone-UCSF Institute of Genomic Immunology, explains the implications of his lab's recent identification of gene networks that control the function of immune cells, known as regulatory T cells, for therapies against cancer and autoimmune diseases.
Gladstone Experts
Autoimmune Diseases
Genomic Immunology
Marson Lab
Gladstone in the News
September 30, 2020
San Francisco Chronicle—Warner Greene, MD, PhD, director of the Center for HIV Cure Research, explains how Timothy Ray Brown, who was cured of HIV/AIDS via a bone marrow transplant, changed the field of HIV research.
Gladstone Experts
HIV/AIDS
Center for HIV Cure Research
Greene Lab
